Literature DB >> 1516606

The influence of levodopa on gastric emptying in healthy elderly volunteers.

D R Robertson1, A G Renwick, B Macklin, S Jones, D G Waller, C F George, J S Fleming.   

Abstract

Paracetamol absorption and 99Tc-DTPA measurements have been used to determine the influence of levodopa on gastric emptying in 8 healthy elderly volunteers. In the absence of levodopa 7 subjects showed a rapid gastric emptying pattern by gamma-camera and a single major peak in the plasma concentration-time curve of paracetamol. One subject showed two rapid phases of gastric emptying separated by a period of negligible emptying and had 2 separate peaks in the paracetamol plasma concentration-time curve. In the presence of levodopa, the gamma-camera data for 6 subjects showed a pattern of gastric emptying consisting of 2 rapid phases separated by a plateau. In each case secondary peaks in the plasma concentration-time curve of paracetamol occurred about 30 min after the end of the plateau. The time to 90% emptying on the gamma scan was increased significantly from 40 min to 65 min in the presence of levodopa. Comparison of the present data with those reported previously indicates that levodopa affects gastric emptying in the both elderly and young volunteers to a similar extent.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1516606     DOI: 10.1007/bf00280127

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa.

Authors:  D R Robertson; N D Wood; H Everest; K Monks; D G Waller; A G Renwick; C F George
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

2.  Duodenal delivery of levodopa for on-off fluctuations in parkinsonism: preliminary observations.

Authors:  R Kurlan; A J Rubin; C Miller; L Rivera-Calimlim; A Clarke; I Shoulson
Journal:  Ann Neurol       Date:  1986-08       Impact factor: 10.422

3.  Variability of L-dopa absorption in man.

Authors:  D N Wade; P T Mearrick; D J Birkett; J Morris
Journal:  Aust N Z J Med       Date:  1974-04

Review 4.  On-off phenomenon: relation to levodopa pharmacokinetics and pharmacodynamics.

Authors:  J G Nutt
Journal:  Ann Neurol       Date:  1987-10       Impact factor: 10.422

5.  Effect of intravenous atropine on gastric emptying, paracetamol absorption, salivary flow and heart rate in young and fit elderly volunteers.

Authors:  M U Rashid; D N Bateman
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

6.  Erratic gastric emptying of levodopa may cause "random" fluctuations of parkinsonian mobility.

Authors:  R Kurlan; K P Rothfield; W R Woodward; J G Nutt; C Miller; D Lichter; I Shoulson
Journal:  Neurology       Date:  1988-03       Impact factor: 9.910

7.  Continuous duodenal infusions of levodopa: plasma concentrations and motor fluctuations in Parkinson's disease.

Authors:  J I Sage; L Schuh; R E Heikkila; R C Duvoisin
Journal:  Clin Neuropharmacol       Date:  1988-02       Impact factor: 1.592

8.  Gastric emptying rate in the elderly: implications for drug therapy.

Authors:  M A Evans; E J Triggs; M Cheung; G A Broe; H Creasey
Journal:  J Am Geriatr Soc       Date:  1981-05       Impact factor: 5.562

9.  Control of on/off phenomenon by continuous intravenous infusion of levodopa.

Authors:  N Quinn; J D Parkes; C D Marsden
Journal:  Neurology       Date:  1984-09       Impact factor: 9.910

10.  Gastric emptying rate and the systemic availability of levodopa in the elderly parkinsonian patient.

Authors:  M A Evans; G A Broe; E J Triggs; M Cheung; H Creasey; P D Paull
Journal:  Neurology       Date:  1981-10       Impact factor: 9.910

View more
  19 in total

Review 1.  How useful is paracetamol absorption as a marker of gastric emptying? A systematic literature study.

Authors:  M Willems; A O Quartero; M E Numans
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

Review 2.  Multiple peaking phenomena in pharmacokinetic disposition.

Authors:  Neal M Davies; Jody K Takemoto; Dion R Brocks; Jaime A Yáñez
Journal:  Clin Pharmacokinet       Date:  2010-06       Impact factor: 6.447

3.  Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation.

Authors:  L Wang; I Magen; P-Q Yuan; S R Subramaniam; F Richter; M-F Chesselet; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2012-07-11       Impact factor: 3.598

4.  Treatment of dysautonomia in extrapyramidal disorders.

Authors:  Tjalf Ziemssen; Heinz Reichmann
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

5.  Unchanged gastric emptying and visceral perception in early Parkinson's disease after a high caloric test meal.

Authors:  L Epprecht; S R Schreglmann; O Goetze; D Woitalla; C R Baumann; D Waldvogel
Journal:  J Neurol       Date:  2015-06-06       Impact factor: 4.849

6.  Ghrelin prevents levodopa-induced inhibition of gastric emptying and increases circulating levodopa in fasted rats.

Authors:  L Wang; N P Murphy; A Stengel; M Goebel-Stengel; D H St Pierre; N T Maidment; Y Taché
Journal:  Neurogastroenterol Motil       Date:  2012-03-23       Impact factor: 3.598

7.  Preventive effect of rikkunshito on gastric motor function inhibited by L-dopa in rats.

Authors:  Lixin Wang; Sachiko Mogami; Hiroshi Karasawa; Chihiro Yamada; Seiichi Yakabi; Koji Yakabi; Tomohisa Hattori; Yvette Taché
Journal:  Peptides       Date:  2014-03-11       Impact factor: 3.750

Review 8.  Treatment of dysautonomia in extrapyramidal disorders.

Authors:  Tjalf Ziemssen; Gerd Fuchs; Wolfgang Greulich; Heinz Reichmann; Michael Schwarz; Birgit Herting
Journal:  J Neurol       Date:  2011-05       Impact factor: 4.849

Review 9.  Pharmacokinetic considerations in gastrointestinal motor disorders.

Authors:  G S Hebbard; W M Sun; F Bochner; M Horowitz
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

10.  Pharmacodynamics of a low subacute levodopa dose helps distinguish between multiple system atrophy with predominant Parkinsonism and Parkinson's disease.

Authors:  Giovanna Calandra-Buonaura; Andrea Doria; Giovanna Lopane; Pietro Guaraldi; Sabina Capellari; Paolo Martinelli; Pietro Cortelli; Manuela Contin
Journal:  J Neurol       Date:  2015-11-14       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.